Published in Biochem J on March 15, 1976
In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest (1990) 2.29
Circulating and tissue angiotensin systems. J Clin Invest (1987) 2.16
Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest (1986) 1.79
Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest (1986) 1.73
Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA. Am J Physiol Renal Physiol (2008) 1.34
Biochemistry and pharmacology of the renin-angiotensin system. Drugs (1990) 1.00
Ultrastructural immunocytochemical localization of renin and angiotensin II in the juxtaglomerular cells of the ischemic kidney in experimental renal hypertension. Am J Pathol (1984) 0.87
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem J (1955) 38.61
Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med (1955) 13.98
A microspectrophotometric method for the determination of cytochrome oxidase. J Biol Chem (1951) 13.45
RENAL HEMODYNAMICS. Am J Med (1964) 3.06
Improved assay methods for renin "concentration" and "activity" in human plasma. Methods using selective denaturation of renin substrate. Circ Res (1967) 3.03
Angiotensin. Physiol Rev (1961) 2.99
RAT-KIDNEY LYSOSOMES: ISOLATION AND PROPERTIES. Biochem J (1965) 2.90
Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme). J Pharmacol Exp Ther (1971) 2.19
Determination of inorganic phosphate in the presence of labile organic phosphates. Anal Biochem (1969) 1.89
Studies on isolated cell components. VIII. High resolution gradient differential centrifugation. Exp Cell Res (1955) 1.77
Renin and angiotensin-like activity in renal lymph. J Physiol (1962) 1.48
The enzymatic degradation of various angiotensin II derivatives by serum, plasma or kidney homogenate. Biochem Pharmacol (1963) 1.45
Extraction, purification, and assay of human renin free of angiotensinase. Circ Res (1966) 1.42
Calcium release induced by interaction of angiotensin with its receptors in smooth muscle cell microsomes. Nature (1972) 1.30
The purification and partial characterization of several forms of hog renin substrate. J Exp Med (1963) 1.26
THE PREPARATION AND CHARACTERIZATION OF FUMARASE FROM SWINE HEART MUSCLE. J Biol Chem (1964) 1.20
Angiotensin II in arterial and renal venous plasma and renal lymph in the dog. J Clin Invest (1971) 1.15
Lysosomes in rat-kidney tissue. Biochim Biophys Acta (1965) 1.10
Angiotensin I-converting enzyme of the kidney cortex. Biochim Biophys Acta (1974) 1.05
Metabolism of angiotensin II in sodium depletion and hypertension in humans. Circ Res (1972) 0.99
Lysosomal acid pyrophosphatase and acid phosphatase. Arch Biochem Biophys (1968) 0.98
Enzyme activities of the single juxtaglomerular apparatus in the rat kidney. Kidney Int (1972) 0.96
The activation of renin in human amniotic fluid by proteolytic enzymes. Biochim Biophys Acta (1972) 0.92
In vitro production of angiotensin I by renal glomeruli. Nature (1969) 0.92
Angiotensin receptors in smooth muscle cell membranes. Nat New Biol (1973) 0.91
Activation of renin in the single juxtaglomerular apparatus by sodium chloride in the tubular fluid at the macula densa. Circ Res (1972) 0.89
Fine structure of normal human juxtaglomerular cells. I. General structure and intercellular relationships. Am J Pathol (1966) 0.88
Hepatic origin of renin substrate. Can J Physiol Pharmacol (1971) 0.85
The conversion of angiotensin I to angiotensin II by rabbit glomeruli. J Endocrinol (1972) 0.85
Effects of endogenous renin on the function of the isolated kidney. Life Sci I (1970) 0.83
Regulation of the in vitro synthesis of angiotensin I. Proc Soc Exp Biol Med (1973) 0.83
Hepatic changes in renin substrate biosynthesis and alkaline phosphatase activity in the rat. Am J Physiol (1972) 0.81
Nature of lysosomal angiotensinase activity. Jpn Circ J (1971) 0.81
Renin, renin substrate, and angiotensin I-converting enzyme in the lymph of rats. Am J Physiol (1971) 0.79
An improved method for the determination of renin in rat kidneys. Pflugers Arch (1971) 0.77
Inhibition of angiotensinases in the rat plasma and kidney. Jpn Heart J (1968) 0.77
Reaction of endogenous renin with exogenous renin substrate within the isolate perfused rat kidney. Proc Soc Exp Biol Med (1973) 0.77
Use of computers in pharmacokinetics. Clin Pharmacol Ther (1967) 0.76
Chronic heart failure in Australian general practice. The Cardiac Awareness Survey and Evaluation (CASE) Study. Med J Aust (2001) 2.71
Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation (1998) 1.87
Developmental expression of ACE2 in the SHR kidney: a role in hypertension? Kidney Int (2006) 1.68
Evidence from cross circulation studies for a humoral mechanism in the natriuresis of saline loading. Proc Soc Exp Biol Med (1966) 1.61
The renin-angiotensin system. Annu Rev Physiol (1978) 1.58
Cross-circulation experiments on the mechanism of the natriuresis during saline loading in the dog. Circ Res (1967) 1.55
Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase. Br Heart J (1989) 1.39
Influence of family history on frequency of glucagon receptor Gly40Ser mutation in hypertensive subjects. Hypertension (1997) 1.39
zif/268 does not mediate increases in proenkephalin mRNA levels after NMDA receptor stimulation. Neuroreport (1994) 1.38
Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria. Eur J Pharmacol (1982) 1.35
Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension. Lancet (1979) 1.34
Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun (1992) 1.30
Angiotensin receptors: distribution, signalling and function. Clin Sci (Lond) (2001) 1.27
High penetrance, overweight, and glucocorticoid receptor variant: case-control study. BMJ (1999) 1.27
Atrial natriuretic peptide in chronic heart failure in the rat: a correlation with ventricular dysfunction. Circ Res (1986) 1.23
hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev (1999) 1.22
Polymerase chain reaction for fast, nonradioactive detection of high- and low-risk papillomavirus types in routine cervical specimens and in biopsies. J Med Virol (1989) 1.20
Primary structure of a human glandular kallikrein gene. DNA (1987) 1.20
Reduced osmotic thirst in healthy elderly men. Am J Physiol (1991) 1.20
Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol (1999) 1.19
ZNF265--a novel spliceosomal protein able to induce alternative splicing. J Cell Biol (2001) 1.16
Angiotensin-converting enzyme inhibitors in the treatment of hypertension. Drugs (1984) 1.15
Swapping health care systems. Whose grass is really greener? JAMA (1996) 1.15
Primary structure of the human renin gene. DNA (1984) 1.12
Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet (1997) 1.12
The effect of bromocriptine on circulating vasopressin. Clin Sci (Lond) (1982) 1.11
Modelling prefrontal cortex deficits in schizophrenia: implications for treatment. Br J Pharmacol (2008) 1.07
Human cardiac myosin heavy chain genes. Isolation of a genomic DNA clone and its characterization and of a second unique clone also present in the human genome. Circ Res (1986) 1.05
Association of HincII RFLP of low density lipoprotein receptor gene with obesity in essential hypertensives. Clin Genet (1995) 1.04
Isolation of renin granules from rat kidney cortex and evidence for an inactive form of renin (prorenin) in granules and plasma. Endocrinology (1976) 1.03
Radioimmunoassay for plasma antidiuretic hormone. J Endocrinol (1972) 1.02
A comparison of chlorothiazide, chlorthalidone and cyclopenthiazide in the treatment of hypertension. Med J Aust (1973) 1.02
Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease. J Mol Med (Berl) (2001) 1.02
Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients. Clin Sci (Lond) (1981) 1.00
Distinct GABAA receptor alpha subunit mRNAs show differential patterns of expression in bovine brain. Neuron (1988) 0.99
Metabolism of angiotensin II in sodium depletion and hypertension in humans. Circ Res (1972) 0.99
Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension. Clin Exp Pharmacol Physiol Suppl (1982) 0.99
Transactivation of the human renin promoter by the cyclic AMP/protein kinase A pathway is mediated by both cAMP-responsive element binding protein-1 (CREB)-dependent and CREB-independent mechanisms in Calu-6 cells. J Biol Chem (1997) 0.99
Enalapril (MK421) activation in man: importance of liver status. Br J Clin Pharmacol (1985) 0.98
Vasopressin in circulatory control and hypertension. J Hypertens (1985) 0.98
Contribution of vasopressin to the maintenance of blood pressure during dehydration. Am J Physiol (1983) 0.97
Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor. Hum Mol Genet (2000) 0.97
Papillomavirus screening of cervical lavages by polymerase chain reaction. Lancet (1988) 0.97
Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands. Endocrinology (1990) 0.97
The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels. Clin Exp Pharmacol Physiol (1975) 0.96
Neurohumoral responses to chronic myocardial infarction in rats. Circulation (1988) 0.95
Renin, angiotensin II, and adrenal corticosteroid relationships during sodium deprivation and angiotensin infusion in normotensive and hypertensive man. Circ Res (1972) 0.95
Inhibition of adenylate cyclase by angiotensin II in rat renal cortex. Endocrinology (1982) 0.95
G-protein beta3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension (1998) 0.95
Activation of Rho GTPases by synaptic transmission in the hippocampus. J Neurochem (2003) 0.94
Plasma renin levels and vascular complications in hypertension. Br Med J (1973) 0.94
Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hypertens (2000) 0.94
Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition. J Hypertens Suppl (1983) 0.94
Localization of endothelin receptors in rat kidney. Eur J Pharmacol (1989) 0.94
The biosynthetic pathway of renin in mouse submandibular gland. J Biol Chem (1983) 0.94
Acute renal haemodynamic and renin-angiotensin system responses to graded renal artery stenosis in the dog. J Physiol (1979) 0.94
Kainate receptors activate NF-kappaB via MAP kinase in striatal neurones. Neuroreport (2000) 0.93
Chronotropic effects of angiotensin I, angiotensin II, bradykinin and vasopressin in guinea pig atria. Eur J Pharmacol (1982) 0.92
Treatment of hypertension with angiotensin converting enzyme inhibitors. Clin Exp Pharmacol Physiol Suppl (1982) 0.92
Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure. Lancet (1984) 0.92
Human papillomavirus: the untreated male reservoir. J Urol (1988) 0.92
The activation of renin in human amniotic fluid by proteolytic enzymes. Biochim Biophys Acta (1972) 0.92
Use of captopril in the diagnosis of renal hypertension. Aust N Z J Med (1981) 0.91
Vasopressin V1 and V2 receptors in diabetes mellitus. Am J Physiol (1994) 0.91
Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels. Am J Cardiol (1982) 0.91
Specific radioactivity of radioimmunoassay tracer determined by self-displacement: a re-evaluation. Clin Chim Acta (1976) 0.90
Regulation of neuronal cell adhesion molecule expression by NF-kappa B. J Biol Chem (2000) 0.90
Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension. Br J Clin Pharmacol (1984) 0.90
Papillomavirus DNA and colposcopy instruments. Lancet (1992) 0.90
Increased cardiac angiotensin-converting enzyme in rats with chronic heart failure. Clin Exp Pharmacol Physiol (1990) 0.90
Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients. Clin Exp Pharmacol Physiol (1981) 0.90
Mouse glandular kallikrein genes. Nucleotide sequence of cloned cDNA coding for a member of the kallikrein arginyl esteropeptidase group of serine proteases. J Biol Chem (1982) 0.90
A review of plasma renin measurements and their clinical significance. Aust N Z J Med (1971) 0.90
Decreased cardiac beta-adrenergic receptors in deoxycorticosterone-salt and renal hypertensive rats. Circ Res (1979) 0.90
Biological significance of renin angiotensin immunization. Circ Res (1970) 0.90
Immunoreactive arginine-vasopressin in Brattleboro rat ovary. Nature (1984) 0.89
Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia. Clin Exp Hypertens (1997) 0.89
Autoradiographic localization in rat brain of kappa opiate binding sites labelled by [3H]bremazocine. Neuroscience (1986) 0.89
Induction of c-fos and zif/268 gene expression in rat striatal neurons, following stimulation of D1-like dopamine receptors, involves protein kinase A and protein kinase C. Neuroscience (1995) 0.89
Molecular characterization of renin-angiotensin system components in human intrauterine tissues and fetal membranes from vaginal delivery and cesarean section. Placenta (2011) 0.88
Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition. Kidney Int (1981) 0.88
Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia. Endocrinology (2001) 0.88
Regional chromosomal assignment of human renin gene to 1q12----qter and use in linkage studies in Charcot-Marie-Tooth disease. Cytogenet Cell Genet (1987) 0.88
Localization of angiotensin converting enzyme in rat heart. Circ Res (1991) 0.88
Stimulation by thyroid hormone of renin mRNA in mouse submandibular gland. Am J Physiol (1986) 0.88
Distribution of Rho family GTPases in the adult rat hippocampus and cerebellum. Brain Res Mol Brain Res (2003) 0.88
In situ hybridization with oligonucleotide probes. Int Rev Neurobiol (2002) 0.88
Inhibition of adenylate cyclase in rat adrenal glomerulosa cells by angiotensin II. Endocrinology (1984) 0.88
Activation of human inactive ("pro-") renin by cathepsin D and pepsin. J Clin Endocrinol Metab (1978) 0.87
Restoration of suppressed baroreflex sensitivity in rats with hereditary diabetes insipidus (Brattleboro rats) by arginine-vasopressin and DDAVP. Circ Res (1983) 0.87
Cross-sectional analysis of Met235-->Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun (1993) 0.87
Controlled trial of enalapril in congestive cardiac failure. Br Heart J (1985) 0.87
Emergency treatment of severe hypertension with intravenous labetalol. Med J Aust (1978) 0.87
Factors associated with clinical and sub-clinical anal human papillomavirus infection in homosexual men. Genitourin Med (1991) 0.87
Effects of deoxycorticosterone on plasma renin acitivity in conscious dogs. Am J Physiol (1969) 0.87
Relation of plasma renin to sodium balance and arterial pressure in experimental renal hypertension. Circ Res (1966) 0.87
The Gly460Trp variant of alpha-adducin is not associated with hypertension in white Anglo-Australians. Am J Hypertens (1999) 0.87
Role of vasopressin in hypertension: studies using the Brattleboro rat. Am J Physiol (1982) 0.87
The contribution of vasopressin and angiotensin to the maintenance of blood pressure after autonomic blockade. Hypertension (1985) 0.86